Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT04919512
Brief Title: A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder (SunRISe-4)

First Submitted : June 8, 2021
First Submitted that Met QC Criteria : June 8, 2021
First Posted : June 9, 2021

Last Update Submitted that Met QC Criteria : January 27, 2022
Last Update Posted : January 28, 2022 (Estimate)